Clinical Trial Update: Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) [Phase 1]

View source ↗

Summary

A Phase 1 trial of Viralym-A (Adenovirus-specific T lymphocytes) sponsored by AlloVir has been withdrawn for Adenovirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection

Drugs mentioned

• Viralym-A

Snippet

Sponsor: AlloVir | Conditions: Adenovirus Infection | Phase 1 | Status: WITHDRAWN